Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A P Cope

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Progress in Growth Factor Research|January 1, 1992
Evaluation of the role of cytokines in autoimmune disease: the importance of TNF alpha in rheumatoid arthritisM Feldmann, F M Brennan, R O Williams, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 21, 2000
Autoantigenic HCgp39 epitopes are presented by the HLA-DM-dependent presentation pathway in human B cellsN S Patil, F C Hall, S Drover, et al.
Lancet (London, England)|December 5, 1992
Meningococcal septicaemia in a C6-deficient patient and effects of plasma transfusion on lipopolysaccharide releaseP J Lehner, K A Davies, M J Walport, et al.
The Journal of Experimental Medicine|June 8, 2001
The transmembrane adaptor protein TRIM regulates T cell receptor (TCR) expression and TCR-mediated signaling via an association with the TCR zeta chainH Kirchgessner, J Dietrich, J Scherer, et al.
Cytokine|May 1, 1993
Differential regulation of tumour necrosis factor receptors (TNF-R) by IL-4; upregulation of P55 and P75 TNF-R on synovial joint mononuclear cellsA P Cope, D L Gibbons, D Aderka, et al.
Arthritis and Rheumatism|August 1, 1993
Correlation between serum levels of soluble tumor necrosis factor receptor and disease activity in systemic lupus erythematosusD Aderka, A Wysenbeek, H Engelmann, et al.
The Journal of Clinical Investigation|August 1, 1994
Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor/CD3 complex; reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritisA P Cope, M Londei, N R Chu, et al.
The Journal of Experimental Medicine|May 5, 1997
Chronic tumor necrosis factor alters T cell responses by attenuating T cell receptor signalingA P Cope, R S Liblau, X D Yang, et al.
Arthritis and Rheumatism|October 1, 1992
Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseasesA P Cope, D Aderka, M Doherty, et al.
Immunological Reviews|January 13, 2000
HLA class II transgenic mice: models of the human CD4+ T-cell immune responseG Sønderstrup, A P Cope, S Patel, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Progress in Growth Factor Research|January 1, 1992
Evaluation of the role of cytokines in autoimmune disease: the importance of TNF alpha in rheumatoid arthritisM Feldmann, F M Brennan, R O Williams, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 21, 2000
Autoantigenic HCgp39 epitopes are presented by the HLA-DM-dependent presentation pathway in human B cellsN S Patil, F C Hall, S Drover, et al.
Lancet (London, England)|December 5, 1992
Meningococcal septicaemia in a C6-deficient patient and effects of plasma transfusion on lipopolysaccharide releaseP J Lehner, K A Davies, M J Walport, et al.
The Journal of Experimental Medicine|June 8, 2001
The transmembrane adaptor protein TRIM regulates T cell receptor (TCR) expression and TCR-mediated signaling via an association with the TCR zeta chainH Kirchgessner, J Dietrich, J Scherer, et al.
Cytokine|May 1, 1993
Differential regulation of tumour necrosis factor receptors (TNF-R) by IL-4; upregulation of P55 and P75 TNF-R on synovial joint mononuclear cellsA P Cope, D L Gibbons, D Aderka, et al.
Arthritis and Rheumatism|August 1, 1993
Correlation between serum levels of soluble tumor necrosis factor receptor and disease activity in systemic lupus erythematosusD Aderka, A Wysenbeek, H Engelmann, et al.
The Journal of Clinical Investigation|August 1, 1994
Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor/CD3 complex; reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritisA P Cope, M Londei, N R Chu, et al.
The Journal of Experimental Medicine|May 5, 1997
Chronic tumor necrosis factor alters T cell responses by attenuating T cell receptor signalingA P Cope, R S Liblau, X D Yang, et al.
Arthritis and Rheumatism|October 1, 1992
Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseasesA P Cope, D Aderka, M Doherty, et al.
Immunological Reviews|January 13, 2000
HLA class II transgenic mice: models of the human CD4+ T-cell immune responseG Sønderstrup, A P Cope, S Patel, et al.
Pageof 5